|
Mar 3
|
Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
|
|
Feb 20
|
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Fai...
|
|
Oct 10
|
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
|
|
Oct 9
|
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares
|
|
Oct 8
|
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
|
|
Jan 9
|
Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis
|
|
Dec 5
|
Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot
|
|
Jun 29
|
Cardiol Therapeutics Reports Results of 2023 Annual General Meeting
|